rawpixel-shutterstock-com-6
Rawpixel / Shutterstock.com
6 November 2015Africa

WTO confirms 17-year extension to LDC patent waiver

The World Trade Organization (WTO) has granted permission for the world’s Least Developed Countries (LDCs) to be exempt from administering and enforcing patents directed to pharmaceutical drugs.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
4 November 2015   The World Trade Organization is expected to announce a 17-year extension to an agreement that exempts the world’s Least Developed Countries from a duty to grant patents covering pharmaceutical drugs, an activist group has claimed.
Americas
20 October 2015   US President Barack Obama has been urged by several non-government organisations to permanently exempt the world’s least developed countries from having to grant patents for pharmaceutical products.

More on this story

Big Pharma
4 November 2015   The World Trade Organization is expected to announce a 17-year extension to an agreement that exempts the world’s Least Developed Countries from a duty to grant patents covering pharmaceutical drugs, an activist group has claimed.
Americas
20 October 2015   US President Barack Obama has been urged by several non-government organisations to permanently exempt the world’s least developed countries from having to grant patents for pharmaceutical products.

More on this story

Big Pharma
4 November 2015   The World Trade Organization is expected to announce a 17-year extension to an agreement that exempts the world’s Least Developed Countries from a duty to grant patents covering pharmaceutical drugs, an activist group has claimed.
Americas
20 October 2015   US President Barack Obama has been urged by several non-government organisations to permanently exempt the world’s least developed countries from having to grant patents for pharmaceutical products.